178 related articles for article (PubMed ID: 8536540)
1. The role of oxidative stress in neuropathy and other diabetic complications.
Van Dam PS; Van Asbeck BS; Erkelens DW; Marx JJ; Gispen WH; Bravenboer B
Diabetes Metab Rev; 1995 Oct; 11(3):181-92. PubMed ID: 8536540
[No Abstract] [Full Text] [Related]
2. The role of oxidative stress in diabetic vascular and neural disease.
Yorek MA
Free Radic Res; 2003 May; 37(5):471-80. PubMed ID: 12797466
[TBL] [Abstract][Full Text] [Related]
3. Diabetic neuropathies.
Sima AA; Thomas PK; Ishii D; Vinik A
Diabetologia; 1997 Oct; 40 Suppl 3():B74-7. PubMed ID: 9345651
[No Abstract] [Full Text] [Related]
4. The aldose reductase controversy.
Frank RN
Diabetes; 1994 Feb; 43(2):169-72. PubMed ID: 8288039
[No Abstract] [Full Text] [Related]
5. [The role of oxidative stress in the development of diabetic neuropathy].
Sztanek F; Molnárné Molnár Á; Balogh Z
Orv Hetil; 2016 Dec; 157(49):1939-1946. PubMed ID: 27917671
[TBL] [Abstract][Full Text] [Related]
6. Symposium on treatment of diabetic complications. 2. Diabetic neuropathy.
Toyota T; Satoh J; Suzuki S
Intern Med; 1997 Feb; 36(2):139-41. PubMed ID: 9099602
[No Abstract] [Full Text] [Related]
7. The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus.
Horrobin DF
Prostaglandins Leukot Essent Fatty Acids; 1988; 31(3):181-97. PubMed ID: 3047752
[No Abstract] [Full Text] [Related]
8. Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved.
Martínez-Blasco A; Bosch-Morell F; Trenor C; Romero FJ
Biofactors; 1998; 8(1-2):41-3. PubMed ID: 9699007
[TBL] [Abstract][Full Text] [Related]
9. [The role of oxidative stress in experimental diabetic neuropathy].
Wang L; Zheng KJ; Dong DY; Sun Y; Wang YM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):108-11. PubMed ID: 21141571
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological alterations of the central nervous system in diabetes mellitus.
Di Mario U; Morano S; Valle E; Pozzessere G
Diabetes Metab Rev; 1995 Oct; 11(3):259-77. PubMed ID: 8536543
[No Abstract] [Full Text] [Related]
11. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications.
Cameron NE; Cotter MA
Diabetes Metab Rev; 1994 Oct; 10(3):189-224. PubMed ID: 7835170
[No Abstract] [Full Text] [Related]
12. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
Obrosova IG; Fathallah L; Stevens MJ
Exp Neurol; 2001 Nov; 172(1):211-9. PubMed ID: 11681853
[TBL] [Abstract][Full Text] [Related]
13. Are mitogen-activated protein kinases glucose transducers for diabetic neuropathies?
Purves TD; Tomlinson DR
Int Rev Neurobiol; 2002; 50():83-114. PubMed ID: 12198822
[No Abstract] [Full Text] [Related]
14. American Diabetes Association Annual Meeting, 1997. Endothelial dysfunction, neuropathy and the diabetic foot, diabetic mastopathy, and erectile dysfunction.
Bloomgarden ZT
Diabetes Care; 1998 Jan; 21(1):183-9. PubMed ID: 9538990
[No Abstract] [Full Text] [Related]
15. Association between silent coronary artery disease, diabetes, and autonomic neuropathy. Fact of fallacy?
Airaksinen KE; Koistinen MJ
Diabetes Care; 1992 Feb; 15(2):288-92. PubMed ID: 1547688
[No Abstract] [Full Text] [Related]
16. Diabetic autonomic neuropathy.
Vinik AI; Freeman R; Erbas T
Semin Neurol; 2003 Dec; 23(4):365-72. PubMed ID: 15088257
[TBL] [Abstract][Full Text] [Related]
17. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
Nagamatsu M; Nickander KK; Schmelzer JD; Raya A; Wittrock DA; Tritschler H; Low PA
Diabetes Care; 1995 Aug; 18(8):1160-7. PubMed ID: 7587852
[TBL] [Abstract][Full Text] [Related]
18. Nerve function and oxidative stress in diabetic and vitamin E-deficient rats.
van Dam PS; van Asbeck BS; Bravenboer B; van Oirschot JF; Gispen WH; Marx JJ
Free Radic Biol Med; 1998 Jan; 24(1):18-26. PubMed ID: 9436610
[TBL] [Abstract][Full Text] [Related]
19. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence.
Kumar A; Negi G; Sharma SS
Diabetes Obes Metab; 2011 Aug; 13(8):750-8. PubMed ID: 21447040
[TBL] [Abstract][Full Text] [Related]
20. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
Kumar A; Kaundal RK; Iyer S; Sharma SS
Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
